PX-1041

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePX-1041

Drug Alias NamePX 104.1HER-2 Protein AutoVacPX-1041

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulantsEpidermal growth factor inhibitors

TargetsEpidermal growth factor

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPharmexa-Epimmune

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPharmexa-Epimmune

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

ATC CodeN/A